Cargando…

The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge

Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to...

Descripción completa

Detalles Bibliográficos
Autores principales: Karabıyık, Afife, Yılmaz, Erkan, Güleç, Şükrü, Haznedaroğlu, İbrahim, Akar, Nejat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781619/
https://www.ncbi.nlm.nih.gov/pubmed/24385723
http://dx.doi.org/10.5152/tjh.2011.41
_version_ 1782285456060186624
author Karabıyık, Afife
Yılmaz, Erkan
Güleç, Şükrü
Haznedaroğlu, İbrahim
Akar, Nejat
author_facet Karabıyık, Afife
Yılmaz, Erkan
Güleç, Şükrü
Haznedaroğlu, İbrahim
Akar, Nejat
author_sort Karabıyık, Afife
collection PubMed
description Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to be investigated. ABS does not affect the levels of coagulation factors II, V, VII, VIII, IX, X, XI and XII. The aim of this study was to investigate the effects of ABS on endothelium and immune response. As such, we evaluated changes in endothelial cell protein C receptor (EPCR) and plasminogen activator inhibitor type-1 (PAI-1) expression inside human umbilical vein endothelial cells (HUVECs) in the presence and absence of lipopolysaccharides (LPSs). Material and Methods: We exposed HUVECs to 10 μL and 100 μL of ABS for 5 min, 25 min, 50 min, 6 h, and 24 h. Additionally, 10 μg mL–1 of LPS was administered for 1 h to observe the effects of LPS challenge on HUVECs, and then the cells were treated with ABS for 5 min, 25 min, 50 min, and 6 h to observe the effects of ABS on HUVECs. Total RNA was isolated from HUVECs and then the level of expression of EPCR and PAI-1 mRNA was measured. Results: Cells were microscopically observed to arise from the surface and adhere to each other following the administration of ABS to HUVECs. Additionally, after 24 h the cells had normal growth and physiology, which suggests that the adhesive cellular effects of ABS might be reversible. ABS had a negative effect on EPCR and PAI-1 expression; the effect in response to 100 µL was greater than that to 10 µL. EPCR and PAI-1 expression increased over time in response to LPS and 10 µL of ABS. EPCR and PAI-1 expression was very low during the first hour of exposure to LPS and 100 µL of ABS, but after 6 h increased to levels similar to those observed in response to LPS and 10 µL of ABS. Conclusion: It was observed that ABS had dual diverse dynamic reversible effects on EPCR and PAI-1 expression in HUVECs, which were dependent on dose and concentration. ABS might play a role in numerous cellular mechanisms, in addition to having hemostatic effects. Conflict of interest:None declared.
format Online
Article
Text
id pubmed-3781619
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-37816192014-01-02 The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge Karabıyık, Afife Yılmaz, Erkan Güleç, Şükrü Haznedaroğlu, İbrahim Akar, Nejat Turk J Haematol Research Article Objective: Ankaferd blood stopper (ABS) is comprised of a mixture of the plants Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia officinarum, and Urtica dioica. ABS is used as a topical hemostatic agent due to its antihemorrhagic effect, yet its hemostatic mechanism of action remains to be investigated. ABS does not affect the levels of coagulation factors II, V, VII, VIII, IX, X, XI and XII. The aim of this study was to investigate the effects of ABS on endothelium and immune response. As such, we evaluated changes in endothelial cell protein C receptor (EPCR) and plasminogen activator inhibitor type-1 (PAI-1) expression inside human umbilical vein endothelial cells (HUVECs) in the presence and absence of lipopolysaccharides (LPSs). Material and Methods: We exposed HUVECs to 10 μL and 100 μL of ABS for 5 min, 25 min, 50 min, 6 h, and 24 h. Additionally, 10 μg mL–1 of LPS was administered for 1 h to observe the effects of LPS challenge on HUVECs, and then the cells were treated with ABS for 5 min, 25 min, 50 min, and 6 h to observe the effects of ABS on HUVECs. Total RNA was isolated from HUVECs and then the level of expression of EPCR and PAI-1 mRNA was measured. Results: Cells were microscopically observed to arise from the surface and adhere to each other following the administration of ABS to HUVECs. Additionally, after 24 h the cells had normal growth and physiology, which suggests that the adhesive cellular effects of ABS might be reversible. ABS had a negative effect on EPCR and PAI-1 expression; the effect in response to 100 µL was greater than that to 10 µL. EPCR and PAI-1 expression increased over time in response to LPS and 10 µL of ABS. EPCR and PAI-1 expression was very low during the first hour of exposure to LPS and 100 µL of ABS, but after 6 h increased to levels similar to those observed in response to LPS and 10 µL of ABS. Conclusion: It was observed that ABS had dual diverse dynamic reversible effects on EPCR and PAI-1 expression in HUVECs, which were dependent on dose and concentration. ABS might play a role in numerous cellular mechanisms, in addition to having hemostatic effects. Conflict of interest:None declared. Galenos Publishing 2012-12 2012-12-05 /pmc/articles/PMC3781619/ /pubmed/24385723 http://dx.doi.org/10.5152/tjh.2011.41 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Karabıyık, Afife
Yılmaz, Erkan
Güleç, Şükrü
Haznedaroğlu, İbrahim
Akar, Nejat
The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
title The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
title_full The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
title_fullStr The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
title_full_unstemmed The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
title_short The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
title_sort dual diverse dynamic reversible effects of ankaferd blood stopper on epcr and pai-1 inside vascular endothelial cells with and without lps challenge
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781619/
https://www.ncbi.nlm.nih.gov/pubmed/24385723
http://dx.doi.org/10.5152/tjh.2011.41
work_keys_str_mv AT karabıyıkafife thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT yılmazerkan thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT gulecsukru thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT haznedarogluibrahim thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT akarnejat thedualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT karabıyıkafife dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT yılmazerkan dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT gulecsukru dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT haznedarogluibrahim dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge
AT akarnejat dualdiversedynamicreversibleeffectsofankaferdbloodstopperonepcrandpai1insidevascularendothelialcellswithandwithoutlpschallenge